Polyethylene glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors.

No abstract is available for this paper.

• Publication year

  1984

• Venue

  International Archives of Allergy and Applied Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000233512PMID 6706424
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins.

  1983cited by this paper
• Antibody responses to honey-bee venom and monomethoxy-polyethylene glycol-modified honey-bee venom in mice.

  1983cited by this paper
• Suppression of reaginic antibodies with modified allergens. III. Preparation of tolerogenic conjugates of common allergens with monomethoxypolyethylene glycols of different molecular weights by the mixed anhydride method.

  1981cited by this paper
• Preparation of a polyethylene glycol: superoxide dismutase adduct, and an examination of its blood circulation life and anti-inflammatory activity.

  1980cited by this paper
• Benzylpenicilloyl-specific serum antibodies to penicillin in man. II. Sensitivity of the hemagglutination assay method, molecular classes of the antibodies detected, and antibody titers of randomly selected patients.

  1966cited by this paper

• Peptide Substitutes of PEG: Biological Outcomes on Prospective Lipid Nanoparticle Shielding Materials.

  2026cites this paper
• Retinal Vascular Occlusion Following COVID-19 Vaccination: A Comprehensive Review of Observational Study and Pathophysiological Mechanisms

  2025influential citation
• Magnetic Nanoworm-Based Screening of Yeast Library for Anti-PEG Nanobodies.

  2025cites this paper
• Polymer Conjugation Benefits Proteins Beyond Simply Extended Half-life.

  2025cites this paper
• Long-acting lipid-based nanomedicines: rethinking from structure-based rational design to in vivo fate evaluation.

  2025cites this paper
• Considering the immunogenicity of PEG: strategies for overcoming issues with PEGylated nanomedicines

  2025cites this paper
• Terminal end groups of poly(ethylene glycol) reduce antigenicity

  2025cites this paper
• Nanourchin-like Uricase-Poly(L-proline) Conjugate with Retained Enzymatic Activity, Mitigated Immunogenicity, and Sustained Efficacy Upon Repeated Administrations.

  2025cites this paper
• Detection of PEG-specific antibodies in SARS-CoV-2 positive and negative sera with implications for autoimmune reactivity

  2025cites this paper
• Sustainable Integration of Nanobiosensors in Biomedical and Civil Engineering: A Comprehensive Review

  2025cites this paper
• Serum albumin nanoparticles: Ligand functionalization for enhanced targeted therapeutics in precision medicine

  2025cites this paper
• Aptamers as immune checkpoint inhibitors in cancer immunotherapy: targeting CTLA-4/B7 and PD-1/PD-L1 pathways.

  2025cites this paper
• Efbemalenograstim Alfa, a Long-Acting Granulocyte Colony-Stimulating Factor Fusion Protein Without PEGylation, Versus Pegfilgrastim for Management of Chemotherapy-Induced Neutropenia in Patients With Breast Cancer: Results of a Phase III Randomized Noninferiority Trial

  2025cites this paper
• Anti-PEG Antibodies and Their Biological Impact on PEGylated Drugs: Challenges and Strategies for Optimization

  2025influential citation
• Polyglycerol-Based Lipids: A Next-Generation Alternative to PEG in Lipid Nanoparticles for Advanced Drug Delivery Systems.

  2025cites this paper
• Better the devil you know than the devil you don’t — PEG challenges in nanomedicine

  2025cites this paper
• A homogeneous immunoassay technology based on liposomes and the complement system enables one-step, no-wash, rapid diagnostics directly in serum

  2025cites this paper
• Engineered nanomaterials and macrophages: Toxicity mechanisms and protective strategies.

  2025cites this paper
• Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin.

  2024cites this paper
• The correlation of asparaginase enzyme activity levels after PEG‐asparaginase administration with clinical characteristics and adverse effects in Chinese paediatric patients with acute lymphoblastic leukaemia

  2024cites this paper
• Polymer-mediated Protein/Peptide Therapeutic Stabilization: Current Progress and Future Directions

  2024cites this paper
• Impact of Anti-PEG IgM Induced via the Topical Application of a Cosmetic Product Containing PEG Derivatives on the Antitumor Effects of PEGylated Liposomal Antitumor Drug Formulations in Mice.

  2024cites this paper
• Development of anti-PEG IgG/IgM/IgE ELISA assays for profiling anti-PEG immunoglobulin response in PEG-sensitized individuals and patients with alpha-gal allergy.

  2024cites this paper
• Protein-polymer bioconjugation, immobilization, and encapsulation: a comparative review towards applicability, functionality, activity, and stability.

  2024cites this paper
• Impact of Pre-existing Anti-polyethylene Glycol Antibodies on the Pharmacokinetics and Efficacy of a COVID-19 mRNA Vaccine (Comirnaty) In Vivo

  2024cites this paper
• Optimizing Pharmacological and Immunological Properties of Therapeutic Proteins Through PEGylation: Investigating Key Parameters and Their Impact

  2024influential citation
• Anti-PEG antibodies: Current situation and countermeasures

  2024cites this paper
• Do Ionic Liquids Exhibit the Required Characteristics to Dissolve, Extract, Stabilize, and Purify Proteins? Past-Present-Future Assessment

  2024cites this paper
• An injectable PEG-like conjugate forms a subcutaneous depot and enables sustained delivery of a peptide drug.

  2023cites this paper
• Rediscovery of poly(ethylene glycol)s as a cryoprotectant for mesenchymal stem cells

  2023cites this paper
• Polyethylene glycol: Properties, applications, and challenges

  2023influential citation
• Poly(oxanorbornene)-Protein Conjugates Prepared by Grafting-to Romp as Alternatives for Peg.

  2023cites this paper
• Anti-drug antibodies against the PEG moiety inhibit the procoagulant activity of therapeutic PEGylated FVIII.

  2023cites this paper
• Analysis of the adverse events following the mRNA-1273 COVID-19 vaccine

  2023influential citation
• Treatment-induced and pre-existing anti-PEG antibodies: Prevalence, clinical implications, and future perspectives.

  2023cites this paper
• Anti-PEG antibodies enriched in the protein corona of PEGylated nanocarriers impact the cell uptake.

  2023cites this paper
• A singlicate immunogenicity method to detect anti-polyethylene glycol antibodies: pre- and post-dose of PEGylated therapies.

  2023cites this paper
• Accelerated blood clearance of PEGylated nanoparticles induced by PEG-based pharmaceutical excipients.

  2023cites this paper
• Discrete Polyethylene glycol Derivatives as a Potent Impetus for Next-Generation Biomedicines

  2023cites this paper
• Liposomes: An emerging carrier for targeting Alzheimer's and Parkinson's diseases

  2022cites this paper
• A Nanomedicine Structure-Activity Framework for Research, Development, and Regulation of Future Cancer Therapies.

  2022cites this paper
• Polynorbornene-based bioconjugates by aqueous grafting-from ring-opening metathesis polymerization reduce protein immunogenicity

  2022cites this paper
• Complement activation-related pseudo allergy of PEGylated products: Safety aspects, models, the role of anti-PEG antibodies, and ways to overcome

  2022cites this paper
• Understanding the Role and Impact of Poly (Ethylene Glycol) (PEG) on Nanoparticle Formulation: Implications for COVID-19 Vaccines

  2022cites this paper
• Chemical Approaches to Synthetic Drug Delivery Systems for Systemic Applications

  2022cites this paper
• PEG: Will It Come Back to You? Polyethelyne Glycol Immunogenicity, COVID Vaccines, and the Case for New PEG Derivatives and Alternatives

  2022influential citation
• Polyethylene Glycol‐Like Brush Polymer Conjugate of a Protein Drug Does Not Induce an Antipolymer Immune Response and Has Enhanced Pharmacokinetics than Its Polyethylene Glycol Counterpart

  2022cites this paper
• Surface Functionalization of Silica Nanoparticles: Strategies to Optimize the Immune-Activating Profile of Carrier Platforms

  2022cites this paper
• Role of Stealth Lipids in Nanomedicine-based drug carriers.

  2021cites this paper
• Methoxy polyethylene glycol modification promotes adipogenesis by inducing the production of regulatory T cells in xenogeneic acellular adipose matrix

  2021cites this paper
• IgG antibodies against polyethylene glycol (PEG) in patient with hemophilia A

  2021cites this paper
• Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles

  2021cites this paper
• Effect of liposome surface modification with water-soluble phospholipid polymer chain-conjugated lipids on interaction with human plasma proteins.

  2021cites this paper
• A Novel 89Zr-labeled DDS Device Utilizing Human IgG Variant (scFv): “Lactosome” Nanoparticle-Based Theranostics for PET Imaging and Targeted Therapy

  2021cites this paper
• Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice.

  2021cites this paper
• To PEGylate or not to PEGylate: immunological properties of nanomedicine's most popular component, poly(ethylene) glycol and its alternatives.

  2021cites this paper
• Aggregation of protein therapeutics enhances their immunogenicity: causes and mitigation strategies

  2021cites this paper
• mRNA, Nanolipid Particles and PEG: A Triad Never Used in Clinical Vaccines is Going to Be Tested on Hundreds of Millions of People

  2021cites this paper
• Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies.

  2021cites this paper
• Immune Responses to PEGylated lipoplexes, a review

  2021cites this paper
• A preliminary study of the innate immune memory of Kupffer cells induced by PEGylated nanoemulsions.

  2021cites this paper
• Clinical Relevance of Pre-Existing and Treatment-Induced Anti-Poly(Ethylene Glycol) Antibodies

  2021cites this paper
• Practical handling of allergic reactions to COVID-19 vaccines

  2021influential citation
• Injectable non-immunogenic PEG-like conjugate that forms a subcutaneous depot and enables sustained delivery of a peptide drug

  2021cites this paper
• Praktischer Umgang mit allergischen Reaktionen auf COVID-19-Impfstoffe

  2021influential citation
• PEGylated Nanoparticles as a Versatile Drug Delivery System

  2021cites this paper
• Flow cytometry analysis of anti-polyethylene glycol antibodies in human plasma☆

  2020cites this paper
• [Induction of Anti-PEG Immune Responses by PEGylation of Proteins].

  2020cites this paper
• PEGylated Liposomal Methyl Prednisolone Succinate does not Induce Infusion Reactions in Patients: A Correlation Between in Vitro Immunological and in Vivo Clinical Studies

  2020cites this paper
• In vivo properties of therapeutic bioconjugates composed of proteins and architecturally/functionally complex polymers

  2020cites this paper
• Immunogenicity Risk Assessment for PEGylated Therapeutics

  2020cites this paper
• Antibodies against polyethylene glycol in human blood: A literature review.

  2020cites this paper
• Nanosized Delivery Systems for Therapeutic Proteins: Clinically Validated Technologies and Advanced Development Strategies

  2020cites this paper
• Site-specific PEGylation of interferon beta-1b

  2020cites this paper
• Anti-PEG antibodies: Properties, formation and role in adverse immune reactions to PEGylated nano-biopharmaceuticals.

  2020cites this paper
• Injectables and Depots to Prolong Drug Action of Proteins and Peptides

  2020cites this paper
• PEG–protein conjugates

  2020cites this paper
• Immunogenicity of Polyethylene Glycol Based Nanomedicines: Mechanisms, Clinical Implications and Systematic Approach

  2020cites this paper
• Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia

  2020cites this paper
• Immunological responses to PEGylated proteins

  2020cites this paper
• Enabling sublingual peptide immunization with molecular self-assemblies.

  2020cites this paper
• Polymer-enhanced biomacromolecules

  2020cites this paper
• Immunogenicity assessment of PEGylated proteins, Lonquex, a PEGylated G-CSF case study

  2020cites this paper
• Liposome and immune system interplay: Challenges and potentials.

  2019cites this paper
• Protein PEPylation: A New Paradigm of Protein-Polymer Conjugation.

  2019cites this paper
• Polyethylene glycols and polysorbates: Two still neglected ingredients causing true IgE-mediated reactions.

  2019cites this paper
• Anti-PEG Antibodies Inhibit the Anticoagulant Activity of PEGylated Aptamers.

  2019cites this paper
• A generic method for the detection of polyethylene glycol specific IgG and IgM antibodies in human serum.

  2019cites this paper
• Accelerated Blood Clearance of Lipid Nanoparticles Entails a Biphasic Humoral Response of B-1 Followed by B-2 Lymphocytes to Distinct Antigenic Moieties

  2019influential citation
• Critical considerations for targeting colorectal liver metastases with nanotechnology

  2019cites this paper
• Both IgM and IgG Antibodies against Polyethylene Glycol Can Alter the Biological Activity of Methoxy Polyethylene Glycol-Epoetin Beta in Mice

  2019cites this paper
• Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker

  2019cites this paper
• Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs.

  2019cites this paper
• Elucidating the Ordering in Self-Assembled Glycocalyx Mimicking Supramolecular Copolymers in Water

  2019cites this paper
• Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro

  2018cites this paper
• Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes

  2018influential citation
• The Power of Shielding: Low Toxicity and High Transfection Performance of Cationic Graft Copolymers Containing Poly(2-oxazoline) Side Chains.

  2018cites this paper
• Bioinspired Shielding Strategies for Nanoparticle Drug Delivery Applications.

  2018cites this paper
• Impact of Polymer Bioconjugation on Protein Stability and Activity Investigated with Discrete Conjugates: Alternatives to PEGylation.

  2018cites this paper
• Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group

  2018cites this paper